Antigenix Therapeutics
Princeton, US · Founded 2024 · Delaware corporation
Healthtech
Founders & leadership
CW
Christopher WhitfieldChief Executive Officer
Board
KF
Kwesi Frimpong-BoatengBoard director
SH
Shaun HawkinsBoard director
Reported raises · per SEC filings
Form D private placements$3.4M disclosed across 1 round · 2025
▶$3.4MraisedOct 2025 · 17 investors · Other Health CareRule 506(b)
▶$3.4MraisedOct 2025 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kwesi Frimpong-BoatengDirector
- Christopher WhitfieldExecutive Officer, Director
- Shaun HawkinsDirector
- Offering amount
- $8.4M
- Amount sold
- $3.4M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Antigenix Therapeutics raised?
- Antigenix Therapeutics has disclosed $3.4M raised across 1 round.
- Where is Antigenix Therapeutics headquartered?
- Antigenix Therapeutics is headquartered in Princeton, US.